NOVO INTEGRATED SCIENCES INC (NVOS) Stock Price, Forecast & Analysis

NASDAQ:NVOS • US67011T3005

0.15 USD
-0.02 (-13.29%)
At close: Nov 5, 2024
0.1132 USD
-0.04 (-24.53%)
After Hours: 11/5/2024, 8:00:01 PM

NVOS Key Statistics, Chart & Performance

Key Statistics
Market Cap2.86M
Revenue(TTM)13.52M
Net Income(TTM)-24.33M
Shares19.05M
Float17.76M
52 Week High1.82
52 Week Low0.15
Yearly DividendN/A
Dividend YieldN/A
EPS(TTM)-1.38
PEN/A
Fwd PEN/A
Earnings (Next)12-11
IPO2005-07-12
Sector
GICS SectorHealth Care
GICS IndustryHealth Care Providers & Services
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Services
NVOS short term performance overview.The bars show the price performance of NVOS in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months -20 -40 -60

NVOS long term performance overview.The bars show the price performance of NVOS in the last 1, 2 and 3 years. 1 year 2 years 3 years -20 -40 -60 -80

The current stock price of NVOS is 0.15 USD. In the past month the price decreased by -39.27%. In the past year, price decreased by -90.74%.

NOVO INTEGRATED SCIENCES INC / NVOS Daily stock chart

NVOS Technical Analysis


Chartmill TA Rating
Chartmill Setup Rating
NVOS Full Technical Analysis Report

NVOS Fundamental Analysis

ChartMill assigns a fundamental rating of 1 / 10 to NVOS. Both the profitability and financial health of NVOS have multiple concerns.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend
NVOS Full Fundamental Analysis Report

NVOS Financial Highlights

Over the last trailing twelve months NVOS reported a non-GAAP Earnings per Share(EPS) of -1.38. The EPS increased by 84.52% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -68.87%
ROE -244.36%
Debt/Equity 0.16
Chartmill High Growth Momentum
EPS Q2Q%-635.41%
Sales Q2Q%-4.2%
EPS 1Y (TTM)84.52%
Revenue 1Y (TTM)1106.87%
NVOS financials

NVOS Forecast & Estimates


Analysts
Analysts0
Price TargetN/A
EPS Next YN/A
Revenue Next YearN/A
NVOS Analyst EstimatesNVOS Analyst Ratings

NVOS Ownership

Ownership
Inst Owners5.23%
Ins Owners1.14%
Short Float %0%
Short Ratio0
NVOS Ownership

NVOS Competitors/Peers

The largest stocks on the US markets in the "Health Care Services" sub-industry
Full List
SymbolCompany NameTechnical RatingFundamental RatingFPEMarket Cap
CVS CVS HEALTH CORP10.6898.698B
CI THE CIGNA GROUP9.1476.435B
BTSGU BRIGHTSPRING HEALTH SERV - BTSG 6 3/4 02/01/2798.8324.484B
LH LABCORP HOLDINGS INC15.6823.109B
DGX QUEST DIAGNOSTICS INC19.2622.736B
GH GUARDANT HEALTH INC N/A13.84B
DVA DAVITA INC11.1410.128B
BTSG BRIGHTSPRING HEALTH SERVICES29.787.421B
CHE CHEMED CORP18.46.622B
OPCH OPTION CARE HEALTH INC18.75.635B

About NVOS

Company Profile

NVOS logo image Novo Integrated Sciences, Inc. engages in the provision of medical services. The company is headquartered in Bellevue, Washington and currently employs 127 full-time employees. The company went IPO on 2005-07-12. The firm owns Canadian and United States subsidiaries that provide, or intend to provide, essential and differentiated solutions to the delivery of multidisciplinary primary care and related wellness products through the integration of medical technology, interconnectivity, advanced therapeutic, diagnostic solutions, personalized product offerings, and rehabilitative science. The firm operates through two segments: Healthcare Services and Product Sales. Its specialized multidisciplinary primary healthcare services include physiotherapy, chiropractic care, manual/manipulative therapy, occupational therapy, eldercare, massage therapy, acupuncture and functional dry needling, chiropody, stroke and traumatic brain injury/neurological rehabilitation, kinesiology, vestibular therapy, dietician and others. Its subsidiaries include Novo Healthnet Limited, Novomerica Health Group, Inc., PRO-DIP, LLC and others.

Company Info

NOVO INTEGRATED SCIENCES INC

11120 Ne 2Nd Street, Suite 100

Bellevue WASHINGTON 98004 US

CEO: Robert Mattacchione

Employees: 179

NVOS Company Website

Phone: 12066179797

NOVO INTEGRATED SCIENCES INC / NVOS FAQ

What does NOVO INTEGRATED SCIENCES INC do?

Novo Integrated Sciences, Inc. engages in the provision of medical services. The company is headquartered in Bellevue, Washington and currently employs 127 full-time employees. The company went IPO on 2005-07-12. The firm owns Canadian and United States subsidiaries that provide, or intend to provide, essential and differentiated solutions to the delivery of multidisciplinary primary care and related wellness products through the integration of medical technology, interconnectivity, advanced therapeutic, diagnostic solutions, personalized product offerings, and rehabilitative science. The firm operates through two segments: Healthcare Services and Product Sales. Its specialized multidisciplinary primary healthcare services include physiotherapy, chiropractic care, manual/manipulative therapy, occupational therapy, eldercare, massage therapy, acupuncture and functional dry needling, chiropody, stroke and traumatic brain injury/neurological rehabilitation, kinesiology, vestibular therapy, dietician and others. Its subsidiaries include Novo Healthnet Limited, Novomerica Health Group, Inc., PRO-DIP, LLC and others.


Can you provide the latest stock price for NOVO INTEGRATED SCIENCES INC?

The current stock price of NVOS is 0.15 USD. The price decreased by -13.29% in the last trading session.


What is the dividend status of NOVO INTEGRATED SCIENCES INC?

NVOS does not pay a dividend.


What is the ChartMill rating of NOVO INTEGRATED SCIENCES INC stock?

NVOS has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 1 out of 10.


What sector and industry does NOVO INTEGRATED SCIENCES INC belong to?

NOVO INTEGRATED SCIENCES INC (NVOS) operates in the Health Care sector and the Health Care Providers & Services industry.


Can you provide the market cap for NOVO INTEGRATED SCIENCES INC?

NOVO INTEGRATED SCIENCES INC (NVOS) has a market capitalization of 2.86M USD. This makes NVOS a Nano Cap stock.